Saudi Consensus Recommendations on the Management of Multiple Sclerosis: Symptom Management and Vaccination

被引:0
作者
Al Thubaiti, Ibtisam A. [1 ]
AlKhawajah, Mona M. [2 ]
Al Fugham, Norah [3 ]
Alissa, Dema A. [4 ]
Al-Jedai, Ahmed H. [4 ]
Al Malik, Yaser M. [5 ]
Almejally, Mousa A. [6 ]
Al-Mudaiheem, Hajer Y. [4 ]
Al-Omari, Bedor A. [7 ]
AlOtaibi, Hessa S. [8 ]
Al Yafeai, Rumaiza H. [9 ]
Babakkor, Mohammed A. [10 ]
Bunyan, Reem F. [11 ]
Cupler, Edward J. [12 ]
Hakami, Mohammed [13 ]
Kedah, Hanaa M. [6 ]
Makkawi, Seraj [14 ,15 ,16 ]
Saeed, Leena H. [17 ]
Saeedi, Jameelah A. [18 ]
Shosha, Eslam [19 ]
Al Jumah, Mohammed A. [20 ]
机构
[1] Dept Neurol, King Fahad Mil Med Complex Dhahran, Dhahran 31932, Saudi Arabia
[2] King Faisal Specialist Hosp & Res Ctr, Dept Neurosci, Riyadh 11564, Saudi Arabia
[3] King Faisal Specialist Hosp & Res Ctr, Neurol Dept, Riyadh 11564, Saudi Arabia
[4] Minist Hlth, Deputyship Therapeut Affairs, Riyadh 12553, Saudi Arabia
[5] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Riyadh 14611, Saudi Arabia
[6] Hera Gen Hosp, Dept Neurol, Mecca 9364, Saudi Arabia
[7] Saudi Soc Clin Pharm SSCP, Saudi Soc Clin Pharm SSCP Makkah Al Mukarramah Rd, Prince Sultan Mil Med City, Makkah Al Mukarramah Rd, Riyadh 12233, Saudi Arabia
[8] King Fahad Hosp, Dept Med, Neurol Unit, Jeddah 23325, Saudi Arabia
[9] Dept Neurol Psychiat & Psychol, My Clin Int Med Co, Jeddah 23617, Saudi Arabia
[10] Dept Neurol, King Abdullah Med City, Makkah Al Mukarramah 24246, Saudi Arabia
[11] King Fahad Specialist Hosp Dammam, Dept Neurol, Dammam 32253, Saudi Arabia
[12] King Faisal Specialist Hosp & Res Ctr, Dept Neurosci, Jeddah 23431, Saudi Arabia
[13] King Fahad Cent Hosp, Neurol Unit, Jazan 140, Saudi Arabia
[14] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Jeddah 22384, Saudi Arabia
[15] King Abdullah Int Med Res Ctr, Jeddah 23816, Saudi Arabia
[16] Minist Natl Guard Hlth Affairs, Dept Med, Jeddah 23235, Saudi Arabia
[17] Dept Pharm, King Fahad Med City, Riyadh 12231, Saudi Arabia
[18] King Abdullah Bin Abdulaziz Univ Hosp, Dept Neurol, Riyadh 11564, Saudi Arabia
[19] McMaster Univ, Dept Med, Div Neurol, Hamilton, ON L8S 4L8, Canada
[20] Dept Neurol, King Fahad Med City, Riyadh 12231, Saudi Arabia
关键词
Saudi consensus; multiple sclerosis; symptom management; vaccinations; patients; ERECTILE DYSFUNCTION; SILDENAFIL CITRATE; DOUBLE-BLIND; IMMUNIZATION; DEPRESSION; DYSPHAGIA; EFFICACY; PLACEBO; FATIGUE; TRIAL;
D O I
10.3390/ctn7010006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This article deals with recommendations on the management of symptoms of MS and on the provision of vaccinations in patients receiving disease-modifying therapies (DMTs). Symptoms of MS, such as fatigue, depression, urinary symptoms, spasticity, impairment of gait, and sexual dysfunction, are common in this population. Recognizing and addressing these symptoms is key to maintaining the quality of life of people with MS. Vaccination status should be reviewed and updated prior to initiation of DMTs. In general, vaccination should be avoided for variable periods after the initiation of some DMTs. Live attenuated vaccines are contraindicated and should be considered on a case-by-case basis. These consensus recommendations will present the best practices for vaccination in Saudi Arabia before, during, and after the COVID-19 pandemic. The recommendations will be updated periodically and as needed as new evidence becomes available.
引用
收藏
页数:16
相关论文
共 73 条
  • [1] COVID-19 and mRNA Vaccines-First Large Test for a New Approach
    Abbasi, Jennifer
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (12): : 1125 - 1127
  • [2] Managing multiple sclerosis in the Covid19 era: a review of the literature and consensus report from a panel of experts in Saudi Arabia
    Al Jumah, Mohammed
    Abulaban, Ahmad
    Aggad, Hani
    Al Bunyan, Reem
    AlKhawajah, Mona
    Al Malik, Yaser
    Almejally, Mousa
    Alnajashi, Hind
    Alshamrani, Foziah
    Bohlega, Saeed
    Cupler, Edward J.
    ElBoghdady, Ahmed
    Makkawi, Seraj
    Qureshi, Shireen
    Shami, Sahar
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 51
  • [3] Saudi Consensus Recommendations on the Management of Multiple Sclerosis: Disease-Modifying Therapies and Management of Relapses
    Al Malik, Yaser M.
    Al Thubaiti, Ibtisam A.
    AlAmmari, Maha A.
    Al Fugham, Norah
    Ali, Eman N.
    Alissa, Dema A.
    Aljarallah, Salman A.
    Al-Jedai, Ahmed H.
    AlKathiri, Maeed A.
    AlKhawajah, Mona M.
    Almejally, Mousa A.
    Al-Mudaiheem, Hajer Y.
    Al Otaibi, Hessa S.
    AlTowaijri, Ghadah H.
    Al Yafeai, Rumaiza H.
    Babakkor, Mohammed A.
    Bohlega, Saeed A.
    Bunyan, Reem F.
    Cupler, Edward J.
    Hakami, Mohammed
    Kareem, Abid M.
    Khardaly, Amr M.
    Makkawi, Seraj
    Saeed, Leena H.
    Saeedi, Jameelah A.
    Shosha, Eslam
    Al Jumah, Mohammad A.
    [J]. CLINICAL AND TRANSLATIONAL NEUROSCIENCE, 2022, 6 (04)
  • [4] An arabic translation, reliability, and validation of Patient Health Questionnaire in a Saudi sample
    AlHadi, Ahmad N.
    AlAteeq, Deemah A.
    Al-Sharif, Eman
    Bawazeer, Hamdah M.
    Alanazi, Hasan
    AlShomrani, Abdulaziz T.
    Shuqdar, Raafat M.
    AlOwaybil, Reem
    [J]. ANNALS OF GENERAL PSYCHIATRY, 2017, 16
  • [5] American Academy of Neurology, 2019, AAN Practice Guideline Summary for Clinicians. Practice Guideline Update: Vaccine-Preventable Infections and Immunization in Multiple Sclerosis
  • [6] [Anonymous], Summary of product characteristics - Eflexor
  • [7] Ashtari F, 2014, J RES MED SCI, V19, P228
  • [8] Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis The VELOCE study
    Bar-Or, Amit
    Calkwood, Jonathan C.
    Chognot, Cathy
    Evershed, Joanna
    Fox, Edward J.
    Herman, Ann
    Manfrini, Marianna
    McNamara, John
    Robertson, Derrick S.
    Stokmaier, Daniela
    Wendt, Jeanette K.
    Winthrop, Kevin L.
    Traboulsee, Anthony
    [J]. NEUROLOGY, 2020, 95 (14) : E1999 - E2008
  • [9] Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis
    Bar-Or, Amit
    Freedman, Mark S.
    Kremenchutzky, Marcelo
    Menguy-Vacheron, Francoise
    Bauer, Deborah
    Jodl, Stefan
    Truffinet, Philippe
    Benamor, Myriam
    Chambers, Scott
    O'Connor, Paul W.
    [J]. NEUROLOGY, 2013, 81 (06) : 552 - 558
  • [10] Insight in booster COVID-19 vaccine and disease modifying therapy in multiple sclerosis
    Beard, Katherine
    Sriwastava, Shitiz
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 430